Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. EVR
EVR logo

EVR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
366.869
Open
361.080
VWAP
360.85
Vol
486.67K
Mkt Cap
14.19B
Low
357.380
Amount
175.61M
EV/EBITDA(TTM)
15.50
Total Shares
39.61M
EV
12.90B
EV/OCF(TTM)
10.27
P/S(TTM)
3.90
Evercore Inc. is an investment banking and investment management company. The Company's segment includes Investment Banking & Equities and Investment Management. Investment Banking & Equities includes the investment banking business through which it provides advice to clients on significant mergers, acquisitions, divestitures, shareholder activism, and other strategic corporate transactions, with a particular focus on advising multinational corporations and private equity firms on large, complex transactions. It also provides liability management and restructuring advice to companies in financial transition, as well as to creditors, shareholders, and potential acquirers. Investment Management includes the wealth management business, through which it provides investment advisory, wealth management and fiduciary services for high-net-worth individuals and associated entities, and the private equity business, which holds interests in private equity funds not managed by the Company.
Show More

Events Timeline

(ET)
2026-02-04
06:50:00
Company Reports Q4 Adjusted Revenue of $1.3B
select

News

Fool
8.5
04-19Fool
Sandisk to Join Nasdaq-100 on April 20, 2025
  • Inclusion in Nasdaq-100: Sandisk is set to join the Nasdaq-100 on April 20, 2025, replacing Atlassian, which underscores its strong demand in the data storage solutions sector, despite Wall Street's general view of overvaluation.
  • Stock Performance and Analysis: The stock has surged over 2,700% in the past year, currently priced at $921, with analysts' median target price at $843, indicating an 8% downside risk; however, some analysts project a potential rise to $2,600, suggesting a 182% upside.
  • Market Share Growth: Sandisk gained 2 percentage points in the NAND flash market over the past year, ranking fourth, yet outpacing industry leader Samsung, highlighting its competitiveness amid soaring AI data center demand.
  • Strong Financial Performance: In Q1 2023, Sandisk's sales jumped 61% to $3 billion, with non-GAAP earnings soaring 404% to $6.20 per share; while future supply-demand imbalances pose risks, the current growth momentum renders its valuation reasonable.
NASDAQ.COM
8.5
04-19NASDAQ.COM
Sandisk Stock Soars 2,700% Ahead of Nasdaq-100 Inclusion
  • Stock Surge: Sandisk's stock has surged 2,700% over the past year, primarily driven by strong demand for its data center storage solutions, and its upcoming inclusion in the Nasdaq-100 is expected to further boost its stock price.
  • Market Share Growth: Although Sandisk ranks fourth in the NAND flash market, it gained 2 percentage points of market share over the past year, indicating its increasing competitiveness amid surging AI data center demand.
  • Strong Financial Performance: In the January quarter of 2023, Sandisk's sales jumped 61% to $3 billion, while non-GAAP adjusted earnings soared 404% to $6.20 per share, reflecting the company's profitability in a rapidly growing market.
  • Future Risks: Despite the current supply shortage driving price increases, analysts warn that increased production capacity may lead to a supply glut in the future, potentially causing NAND prices to fall significantly, prompting investors to approach the stock's high valuation with caution.
NASDAQ.COM
2.0
04-18NASDAQ.COM
Teva's FDA Approval of Long-Acting Drug Could Be Major Catalyst
  • New Drug Approval Outlook: Teva's New Drug Application for long-acting schizophrenia drug olanzapine has been accepted by the FDA, and if approved, it is expected to significantly enhance patient adherence, driving sales growth and becoming the company's most meaningful catalyst.
  • Specialty Drug Sales Surge: Teva's Austedo generated $2.26 billion in sales in 2025, marking a 34% year-over-year increase, with expectations to reach between $2.4 billion and $2.55 billion in 2026, showcasing strong momentum in the specialty drug sector.
  • Biosimilar Market Expansion: Teva plans to launch six new biosimilars in 2026 and 2027, potentially competing with Amgen and Johnson & Johnson, which will further solidify its position as the second-largest player in the biosimilar market.
  • Investor Confidence Boost: Analysts are optimistic about Teva's future, with 12 out of 15 analysts rating the stock as a
Fool
8.5
04-18Fool
Teva Pharmaceutical Shares Surge 130% with Optimistic Outlook
  • FDA Approval Catalyst: Teva's long-acting olanzapine injectable suspension NDA has been accepted by the FDA, with a decision expected later this year; approval could significantly enhance patient adherence, with combined annual sales with Uzedy projected to exceed $2 billion.
  • Specialty Drug Sales Surge: Teva's specialty drug Austedo generated $2.26 billion in sales in 2025, a 34% year-over-year increase, with expectations for 2026 sales to rise between $2.4 billion and $2.55 billion, reflecting strong market demand and competitive positioning in the specialty drug sector.
  • Biosimilar Expansion: Teva plans to launch six new biosimilars in 2026 and 2027, further solidifying its position as the second-largest player in the biosimilar market, with anticipated competition against giants like Amgen and Johnson & Johnson, driving future revenue growth.
  • Market Risk Factors: Despite several catalysts propelling stock price growth, a market crash or significant pipeline issues could derail Teva's momentum; however, the company's pipeline is relatively de-risked, and with a forward P/E of only 11.7, it presents a compelling value investment opportunity.
CNBC
8.0
04-15CNBC
US Blockade of Strait of Hormuz Strains Relations with China and India
  • Strained US-China Relations: The US blockade of the Strait of Hormuz not only intensifies pressure on Iran but also risks destabilizing the fragile relationship with China, particularly with a summit between Trump and Xi Jinping approaching, which could impact economic cooperation and strategic stability.
  • Rising Energy Risks for India: After resuming oil and gas imports from Iran, India faces a conflict between US policy and its economic interests, especially regarding energy supply vulnerabilities, which may lead to further deterioration in relations with Washington.
  • China's Resilience: Despite the energy shock, China's substantial oil stockpiles and diversified energy mix allow it to manage the situation relatively well, with expectations that it can compensate for lost Iranian oil through alternative sources and increased coal usage.
  • India's Strategic Shortcomings: India's lack of strategic reserves for liquefied petroleum gas poses significant economic risks, particularly if Middle Eastern supplies are disrupted, potentially leading to shortages for households and businesses, which could affect social stability.
Yahoo Finance
2.0
04-02Yahoo Finance
Financial Stocks Underperform, Investors Remain Cautious
  • Industry Challenges: Financial stocks have collectively dropped 8.8% over the past six months due to an unpredictable interest rate and inflation environment, significantly underperforming the S&P 500's 2.8% decline, indicating investor concerns about the sector's outlook.
  • State Street's Lackluster Performance: With a market cap of $35.75 billion, State Street has seen only 3.6% annual revenue growth over the past five years, and its EPS growth of 9.1% annually falls short of the peer group average, reflecting limited growth potential compared to smaller competitors.
  • Raymond James's Strong Growth: Raymond James, valued at $28.26 billion, has achieved an impressive 11.7% annual revenue growth over the last five years, bolstered by share buybacks that accelerated EPS growth, showcasing management's expertise in identifying profitable investments.
  • Evercore's Market Share Gains: Evercore, with a market cap of $11.93 billion, has reported a remarkable 25.9% annual revenue growth over the last two years, with EPS increasing by 50.2% annually, indicating its success in capturing market share during the current cycle.
Wall Street analysts forecast EVR stock price to rise
6 Analyst Rating
Wall Street analysts forecast EVR stock price to rise
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
342.36
Averages
389.87
High
425.00
Current: 0.000
sliders
Low
342.36
Averages
389.87
High
425.00
Goldman Sachs
James Yaro
Buy
maintain
$335 -> $374
AI Analysis
2026-04-14
Reason
Goldman Sachs
James Yaro
Price Target
$335 -> $374
AI Analysis
2026-04-14
maintain
Buy
Reason
Goldman Sachs analyst James Yaro raised the firm's price target on Evercore to $374 from $335 and keeps a Buy rating on the shares. Earnings estimates and price targets for investment banks were modestly adjusted based on final Dealogic data, reflecting slight increases in M&A and debt capital markets activity with equity capital markets unchanged, the analyst tells investors in a research note.
Morgan Stanley
Equal Weight
maintain
$381 -> $384
2026-04-09
Reason
Morgan Stanley
Price Target
$381 -> $384
2026-04-09
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Evercore to $384 from $381 and keeps an Equal Weight rating on the shares. The firm expects midcap advisor management teams to express cautious optimism amid recent volatility, but comp ratios could disappoint as managements await clarity on the full-year revenue environment, the analyst tells investors in a preview for the group.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for EVR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Evercore Inc (EVR.N) is 20.12, compared to its 5-year average forward P/E of 16.74. For a more detailed relative valuation and DCF analysis to assess Evercore Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
16.74
Current PE
20.12
Overvalued PE
21.27
Undervalued PE
12.21

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
10.71
Current EV/EBITDA
10.48
Overvalued EV/EBITDA
11.88
Undervalued EV/EBITDA
9.54

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
2.32
Current PS
2.66
Overvalued PS
2.84
Undervalued PS
1.80

Financials

AI Analysis
Annual
Quarterly

Whales Holding EVR

C
Ceredex Value Advisors LLC
Holding
EVR
+17.35%
3M Return
P
Polar Asset Management Partners Inc.
Holding
EVR
+14.12%
3M Return
S
Stacey Braun Associates, Inc.
Holding
EVR
+13.51%
3M Return
C
Cookson Peirce & Co Inc
Holding
EVR
+12.96%
3M Return
T
Tremblant Capital Group
Holding
EVR
+8.20%
3M Return
S
Scout Investments, Inc.
Holding
EVR
+7.16%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Evercore Inc (EVR) stock price today?

The current price of EVR is 358.29 USD — it has decreased -1.27

What is Evercore Inc (EVR)'s business?

Evercore Inc. is an investment banking and investment management company. The Company's segment includes Investment Banking & Equities and Investment Management. Investment Banking & Equities includes the investment banking business through which it provides advice to clients on significant mergers, acquisitions, divestitures, shareholder activism, and other strategic corporate transactions, with a particular focus on advising multinational corporations and private equity firms on large, complex transactions. It also provides liability management and restructuring advice to companies in financial transition, as well as to creditors, shareholders, and potential acquirers. Investment Management includes the wealth management business, through which it provides investment advisory, wealth management and fiduciary services for high-net-worth individuals and associated entities, and the private equity business, which holds interests in private equity funds not managed by the Company.

What is the price predicton of EVR Stock?

Wall Street analysts forecast EVR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EVR is389.87 USD with a low forecast of 342.36 USD and a high forecast of 425.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Evercore Inc (EVR)'s revenue for the last quarter?

Evercore Inc revenue for the last quarter amounts to 1.29B USD, increased 32.58

What is Evercore Inc (EVR)'s earnings per share (EPS) for the last quarter?

Evercore Inc. EPS for the last quarter amounts to 4.76 USD, increased 44.24

How many employees does Evercore Inc (EVR). have?

Evercore Inc (EVR) has 2570 emplpoyees as of April 21 2026.

What is Evercore Inc (EVR) market cap?

Today EVR has the market capitalization of 14.19B USD.